US EditionModerna authorised to upscale development of mRNA vaccines in UK - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Moderna authorised to upscale development of mRNA vaccines in UK - Pharmafile
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture commercial mRNA vaccines at its facility in Harwell, Oxfordshire, UK. This is a milestone in Moderna’s mission to develop a reliable supply of mRNA vaccines for pandemic-preparedness. The MHRA granted Manufacturer’s/Importer’s Authorisation (MIA) to […] The post Moderna authorised to upscale…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
